StonvexLoading…
StonvexStonvexStonvexCore line items from FORM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-28 | Annual 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $244.80M | $226.14M | $784.99M | $569.83M | $367.15M |
Operating Income | Not available | $16.65M | $57.07M | $33.58M | $15.57M |
Net Income | Not available | $20.38M | $54.36M | $31.14M | $15.49M |
EPS (Diluted) | $0.62 | $0.26 | $0.69 | $0.40 | $0.20 |
Total Assets | Not available | $1.26B | $1.22B | $1.20B | $1.18B |
Total Liabilities | Not available | $197.05M | $188.96M | $193.38M | $191.59M |
Cash & Equivalents | Not available | $123.54M | $103.33M | $97.68M | $67.38M |
Free Cash Flow OCF − CapEx | Not available | $29.77M | $11.74M | $-22.92M | $-42.41M |
Shares Outstanding | Not available | 77.95M | 77.65M | 77.52M | 77.11M |